Lyon-based company creating genetically engineered and humanized rodent models, with catalog models and in vivo research services.
Hospital-based preclinical research unit in Israel offering GLP and non-GLP large animal studies, catheterization and cardiovascular device models.
Danish preclinical CRO and peptide discovery company known for metabolic, liver and kidney disease models with AI-supported histology and 3D imaging readouts.
AAALAC-accredited Japanese CRO specializing in nonhuman primate disease models for preclinical efficacy and proof of concept.
Kentucky CRO developing immunodeficient rat and mouse models, offering xenograft efficacy and safety studies in larger rodent hosts.
Online histology service lab providing tissue processing, staining, IHC, whole-slide scanning and pathology review for research teams.
Korean non-clinical CRO focused on efficacy testing of new drug candidates, with research facilities in Songdo, Incheon.
Preclinical CRO focused on rodent models of autoimmune and inflammatory disease, such as EAE, arthritis and colitis, with supporting histology, cytokine analysis and flow cytometry.
Wuhan CRO integrating NHP breeding with toxicity and safety evaluation, PK/PD, molecular imaging and bioanalysis.
Maryland CRO specializing in infectious disease and vaccine research, offering in vitro and in vivo efficacy models and immunological assays.
Minnesota company providing preclinical services and reagents for oncolytic virus, gene and cell therapy programs, including reporter imaging and efficacy models.
Shanghai-based nonclinical CRO with GLP safety evaluation, pharmacology, DMPK, bioanalysis and biomarker services for small molecules, biologics and cell and gene therapies, operating several sites in China.
Indian GLP test facility offering regulatory toxicology studies for chemicals, agrochemicals and pharmaceuticals.
Ophthalmology-dedicated CRO near Nice offering ocular efficacy models, GLP ocular safety and PK, bioanalysis and clinical services.
Indian GLP CRO providing regulatory toxicology and safety studies for pharmaceuticals, agrochemicals, chemicals and biologics.
Spanish translational research center offering GLP and non-GLP large animal studies, device validation, advanced imaging and surgical training.
Large China-based nonclinical CRO offering GLP safety assessment, pharmacology, pharmacokinetics and bioanalysis, with operations in China and the United States.
Indian integrated drug discovery CRO offering in vivo pharmacology and DMPK alongside chemistry and biology.
Korean nonhuman primate CRO in the Biotoxtech group with GLP repeat-dose toxicity and cardiovascular safety pharmacology in NHPs, plus NHP inhalation studies.
Houston preclinical CRO near the Texas Medical Center with an AAALAC-accredited mouse vivarium, in vivo pharmacology and flexible lab space.
Bioanalytical and biomarker CRO supporting preclinical and clinical programs with LC-MS/MS, ligand binding, flow cytometry and cell and gene therapy assays, with sites in the US and France.